NPPB and heart failure: For example, despite the expected rise in NT-proBNP with weight loss, pivotal studies show semaglutide produces a significantly greater reduction in NT-proBNP and fewer heart-failure events, suggesting decongestive and favorable hemodynamic effects that may be particularly consequential beyond weight loss.